Michael Soo

Michael Soo currently serves as Director at Fenix Group International, LLC, a firm specializing in advisement and analytics within the life sciences sector, leveraging innovative methods for market opportunity assessment. Prior experience includes various leadership roles in oncology at the University of Pennsylvania School of Medicine, where substantial contributions included initiating collaborative research projects and optimizing scientific methodologies. Additional experience encompasses healthcare consulting at The Wharton School, where strategic advisement was provided to a Fortune 500 company, and a graduate teaching assistantship in a critical cell biology course at the University of Pennsylvania. Michael holds a Ph.D. in Biochemistry and Molecular Biophysics and a B.A. in Political Science and Chemistry from the University of Pennsylvania.